Source comparison
CJC-1295 Support Natural GH Elevation Research: Comparison Table
CJC-1295 with DAC GHRH analog with albumin binding via drug affinity complex 6–8 days Weekly or bi-weekly Chronic metabolic studies, body recomposition, aging research Sustained moderate elevation with preserved pulsatility across 7-day window Best for long-te
This comparison does not assign a generated winner or score.
- CJC-1295 with DAC
- GHRH analog with albumin binding via drug affinity complex
- 6–8 days
- Weekly or bi-weekly
- Chronic metabolic studies, body recomposition, aging research
- Sustained moderate elevation with preserved pulsatility across 7-day window
- Best for long-term research requiring stable GH elevation without daily dosing
- Modified GRF (1-29)
- GHRH analog without DAC, DPP-IV resistant
- 30–60 minutes
- 1–3 times daily
- Acute GH release studies, post-exercise recovery, circadian timing research
- Sharp, discrete pulses lasting 2–4 hours per injection
- Ideal for studying acute signalling cascades and timing-dependent GH effects
- GHRP-2
- Synthetic ghrelin mimetic, somatostatin inhibitor
- 20–30 minutes
- 2–3 times daily
- Synergistic protocols with GHRH analogs, appetite signalling research
- Rapid, pronounced pulse with 10–20× baseline GH elevation for 30–60 minutes
- Most effective when combined with GHRH analogs due to dual-pathway activation
- MK-677 (Ibutamoren)
- Oral ghrelin receptor agonist
- 24 hours
- Once daily
- Oral administration research, chronic appetite/muscle studies, compliance-focused protocols
- Sustained moderate elevation without injections, slightly blunted pulsatility
- Convenient for research requiring oral dosing, though less pronounced GH peaks than injectable peptides